Ingevec Bilan de santé

Santé financière contrôle des critères 4/6

Ingevec possède un total de capitaux propres de CLP84.8B et une dette totale de CLP86.2B, ce qui porte son ratio d'endettement à 101.7%. Son actif total et son passif total sont CLP242.3B et de CLP157.5B. L'EBIT de Ingevec est CLP12.1B ce qui fait que son ratio de couverture des intérêts 3.4. Elle dispose de liquidités et de placements à court terme de CLP16.1B.

Informations clés

101.7%

Ratio d'endettement

CL$86.23b

Dette

Ratio de couverture des intérêts	3.4x
Argent liquide	CL$16.11b
Fonds propres	CL$84.80b
Total du passif	CL$157.55b
Total des actifs	CL$242.35b

Mises à jour récentes de la santé financière

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Jun 14

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Jan 11

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Apr 12

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Jan 11

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Ingevec S.A.'s (SNSE:INGEVEC) Performance Completely

Jan 26

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Jun 14

A Look At The Intrinsic Value Of Ingevec S.A. (SNSE:INGEVEC)

Feb 16

Slowing Rates Of Return At Ingevec (SNSE:INGEVEC) Leave Little Room For Excitement

Sep 02

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Jan 11

Key Things To Consider Before Buying Ingevec S.A. (SNSE:INGEVEC) For Its Dividend

Jan 26

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Jan 11

Did You Participate In Any Of Ingevec's (SNSE:INGEVEC) Incredible 423% Return?

Dec 23

We Wouldn't Rely On Ingevec's (SNSE:INGEVEC) Statutory Earnings As A Guide

Dec 01

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de INGEVEC ( CLP118.1B ) ne couvrent pas ses passifs à court terme ( CLP128.5B ).

Passif à long terme: Les actifs à court terme de INGEVEC ( CLP118.1B ) dépassent ses passifs à long terme ( CLP29.0B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de INGEVEC ( 82.7% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de INGEVEC a été réduit de 117.6% à 101.7% au cours des 5 dernières années.

Couverture de la dette: La dette de INGEVEC est bien couverte par le flux de trésorerie opérationnel ( 20.6% ).

Couverture des intérêts: Les paiements d'intérêts de INGEVEC sur sa dette sont bien couverts par l'EBIT ( 3.4 x couverture).

Ingevec Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: EPS: CL$2.82 (vs CL$2.07 in 3Q 2023)

Upcoming dividend of CL$2.90 per share

First quarter 2024 earnings released: EPS: CL$3.00 (vs CL$2.70 in 1Q 2023)

New major risk - Financial position

Full year 2023 earnings released: EPS: CL$9.70 (vs CL$9.30 in FY 2022)

Even With A 26% Surge, Cautious Investors Are Not Rewarding Ingevec S.A.'s (SNSE:INGEVEC) Performance Completely

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: EPS: CL$2.07 (vs CL$2.24 in 3Q 2022)

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CL$2.68 (vs CL$2.49 in 2Q 2022)

Investor sentiment improves as stock rises 17%

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Extensively

Full year 2022 earnings released: EPS: CL$9.30 (vs CL$8.60 in FY 2021)

A Look At The Intrinsic Value Of Ingevec S.A. (SNSE:INGEVEC)

Now 21% undervalued after recent price drop

Less than half of directors are independent

Investor sentiment improved over the past week

Slowing Rates Of Return At Ingevec (SNSE:INGEVEC) Leave Little Room For Excitement

Second quarter 2022 earnings released: EPS: CL$2.49 (vs CL$2.08 in 2Q 2021)

First quarter 2022 earnings released: EPS: CL$2.70 (vs CL$2.20 in 1Q 2021)

Upcoming dividend of CL$4.30 per share

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

These 4 Measures Indicate That Ingevec (SNSE:INGEVEC) Is Using Debt Reasonably Well

The Returns At Ingevec (SNSE:INGEVEC) Aren't Growing

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CL$2.21 (vs CL$0.97 in 3Q 2020)

Second quarter 2021 earnings released: EPS CL$2.08 (vs CL$0.06 in 2Q 2020)

Here's What's Concerning About Ingevec's (SNSE:INGEVEC) Returns On Capital

First quarter 2021 earnings released: EPS CL$2.20 (vs CL$1.72 in 1Q 2020)

Upcoming dividend of CL$1.56 per share

Calculating The Fair Value Of Ingevec S.A. (SNSE:INGEVEC)

Upcoming dividend of CL$1.56 per share

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Full year 2020 earnings released: EPS CL$5.20 (vs CL$7.80 in FY 2019)

New 90-day high: CL$90.00

Here’s What’s Happening With Returns At Ingevec (SNSE:INGEVEC)

Is Ingevec S.A.'s (SNSE:INGEVEC) ROE Of 9.7% Impressive?

Key Things To Consider Before Buying Ingevec S.A. (SNSE:INGEVEC) For Its Dividend

Does Ingevec (SNSE:INGEVEC) Have A Healthy Balance Sheet?

Did You Participate In Any Of Ingevec's (SNSE:INGEVEC) Incredible 423% Return?

New 90-day low: CL$79.78

We Wouldn't Rely On Ingevec's (SNSE:INGEVEC) Statutory Earnings As A Guide

Third quarter 2020 earnings released: EPS CL$0.97

New 90-day low: CL$82.25

New 90-day low: CL$85.20

First half earnings released

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines